Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Xu

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 18, 2016
[Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients]H M Li, P Yuan, D K Yu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 25, 2021
[Analysis of the effect of ipsilateral supraclavicular lymph node metastasis on the prognosis of N3 breast cancer]Abudureheiyimu Nilupai, J Y Wang, Q Li, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|February 22, 2021
[Analyses of triggers for recurrent cardiac events in 38 patients with symptomatic long QT syndrome]K Li, F She, J Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 1, 2020
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients]K P Ou, Q Li, Y Luo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 22, 2017
[Correlations between genetic variations of glutathione synthetase gene and the response to platinum-based chemotherapy and prognosis of small cell lung cancer patients]T Feng, H M Li, P Yuan, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 6, 2018
[Clinical observation of thyroid-related adverse events induced by anti-PD-1 antibody SHR-1210 in patients with advanced solid tumor]L Qi, H N Mo, X L Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 21, 2022
[A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer]Z J Wang, Y Q Han, Q Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 14, 2023
[Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer: a prospective cohort study]M Xiu, Y Lu, X Wang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 18, 2021
[Treatment efficiency evaluation of left cardiac sympathetic denervation for patients with inherited arrhythmia by exercise-stress test]J Yang, K Li, D H Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 29, 2019
[Feasibility and toxicity of EC-T dose-dense adjuvant chemotherapy: A real world study in Chinese early-stage breast cancer patients with high recurrence risk]J N Wang, Y X Mu, Q Li, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 18, 2016
[Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients]H M Li, P Yuan, D K Yu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 25, 2021
[Analysis of the effect of ipsilateral supraclavicular lymph node metastasis on the prognosis of N3 breast cancer]Abudureheiyimu Nilupai, J Y Wang, Q Li, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|February 22, 2021
[Analyses of triggers for recurrent cardiac events in 38 patients with symptomatic long QT syndrome]K Li, F She, J Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 1, 2020
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients]K P Ou, Q Li, Y Luo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 22, 2017
[Correlations between genetic variations of glutathione synthetase gene and the response to platinum-based chemotherapy and prognosis of small cell lung cancer patients]T Feng, H M Li, P Yuan, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 6, 2018
[Clinical observation of thyroid-related adverse events induced by anti-PD-1 antibody SHR-1210 in patients with advanced solid tumor]L Qi, H N Mo, X L Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 21, 2022
[A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer]Z J Wang, Y Q Han, Q Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 14, 2023
[Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer: a prospective cohort study]M Xiu, Y Lu, X Wang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 18, 2021
[Treatment efficiency evaluation of left cardiac sympathetic denervation for patients with inherited arrhythmia by exercise-stress test]J Yang, K Li, D H Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 29, 2019
[Feasibility and toxicity of EC-T dose-dense adjuvant chemotherapy: A real world study in Chinese early-stage breast cancer patients with high recurrence risk]J N Wang, Y X Mu, Q Li, et al.
Pageof 7